A federal jury hit DePuy Synthes with a $20 million verdict payable to a surgeon who said the Johnson & Johnson (NYSE:JNJ) orthopedic unit stole his patented technology. The surgeon, Dr. Gary Lynn Rasmussen of Utah, invented a device for aligning and positioning the prosthesis in knee replacement procedures, according to court records. He applied […]
Featured
Johnson & Johnson Medical Devices drops ‘medical devices’ in rebranding
Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology. New Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ) noted the coming change in its 2022 annual report published last month, saying the switch would take effect in the company’s first fiscal quarter. That preview […]
Pear Therapeutics says new data backs its prescription digital therapeutic for insomnia
Pear Therapeutics (Nasdaq:PEAR) today announced data from two studies that highlight the effectiveness of its chronic insomnia treatment. Boston-based Pear Therapeutics designed its Somryst prescription digital therapeutic (PDT) to address the underlying issues of chronic insomnia by delivering cognitive behavioral therapy for insomnia (CBTi), training the body to sleep. The nine-week PDT can be used on […]
GE Healthcare to roll out AI-powered Edison Digital Health Platform
GE Healthcare (NYSE:GE) today announced plans for its Edison Digital Health Platform. The news was part of HIMSS 2022 in Orlando, Florida, where GE Healthcare officials described Edison as a vendor-agnostic hosting and data aggregation platform with an integrated AI engine. The Edison Digital Health Platform could enable health providers to effectively deploy clinical, workflow, […]
Augmedics adds former J&J, Medtronic executives to leadership positions
Augmedics announced today that it appointed a new independent director to its board and a new chief marketing officer. Chicago-based Augmedics confirmed that Nadav Tomer will join as an independent director, while Reed Krider will be chief marketing officer (CMO). Tomer joins with 23 years of global experience, having retired from Johnson & Johnson in […]
Vivasure treats first patient in U.S. study for next-gen PerQseal+ in TAVR procedures
Vivasure Medical announced today that the first patient was treated in a U.S. early feasibility study of its next-generation PerQseal+ device. Galway, Ireland-based Vivasure’s study will evaluate PerQseal+ in percutaneous transcatheter aortic valve replacement (TAVR) procedures. The first patient was treated by Dr. Robert Pyo at Stony Brook University Hospital in Stony Brook, New York. […]
FDA clears Philips Capsule Surveillance for remote patient monitoring
Royal Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its latest Philips Capsule Surveillance system. Amsterdam-based Philips designed its Philips Capsule Surveillance solution to aggregate patient data, analyze the data to generate actionable insights and alerts and send timely notifications to caregivers so they can intervene before any patient deterioration progresses further. […]
DeepWell Digital Therapeutics launches to develop video games for treating health issues
DeepWell Digital Therapeutics, a video game developer aiming to combine games and health treatments, was unveiled today. Seattle-based DeepWell aims to create best-in-class gameplay that can simultaneously entertain and deliver, enhance and accelerate treatment for an array of globally pervasive health conditions, according to a news release. Devolver Digital co-founder Mike Wilson and Nextern founder […]
DeviceTalks Boston returns with a unique approach for medtech connections and development
A few months back, I wrote what was best described by a colleague as a “salty” Medical Design & Outsourcing column in which I demanded conference organizers like myself step up our game if we expect to bring back attendees. “For too long, conference organizers have relied upon a potent cocktail of FOMO and habit,” […]
Former CEO Kevin King to retire from iRhythm’s board of directors
iRhythm Technologies (Nasdaq:IRTC) announced today that Kevin King will retire from the company’s board of directors. King joined San Francisco–based iRhythm’s board in July 2012 and served as the company’s president and CEO from then until January 2021. “On behalf of the entire iRhythm team, I would like to thank Kevin for his contributions over […]
FDA clears Fresenius Kabi wireless Agilia Connect infusion system
Fresenius Kabi announced today that it received FDA 510(k) clearance for its wireless Agilia Connect infusion system. Lake Zurich, Illinois–based Fresenius Kabi’s Agilia Connect infusion system includes the Agilia volumetric pump and the Agilia syringe pump with Vigilant software suite-Vigilant Master Med technology. Get the full story at our sister site, Drug Delivery Business News.